NORAD exacerbates metabolic dysfunction-associated steatotic liver disease development via the miR-511-3p/Rock2 axis and inhibits ubiquitin-mediated degradation of ROCK2

作者：Xu Zhang, Tianxing Chen, Zhenhan Li, Lingfeng Wan, Zhihang Zhou, Ying Xu, Dong Yan, Wei Zhao, Hao Chen · 发表于：Metabolism · 年份：2024 · DOI：10.1016/j.metabol.2024.156111 · 被引用次数：15 · 研究领域：Liver Disease Diagnosis and Treatment、Cancer-related molecular mechanisms research、Liver Diseases and Immunity